SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-15-002286
Filing Date
2015-04-30
Accepted
2015-04-30 17:30:40
Documents
5
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 3967
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 313404
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 3004
4 GRAPHIC exhibi1.jpg GRAPHIC 12633
5 GRAPHIC exhibi2.jpg GRAPHIC 33854
  Complete submission text file 0001062993-15-002286.txt   385669
Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 15820590
SIC: 2834 Pharmaceutical Preparations